A prospective observational study of the clinical and pathological impact of stereotactic body radiotherapy (SBRT) as a neoadjuvant strategy of chemoradiation in pancreatic cancer.
Xin Chen-ZhaoO HernandoM LópezE SánchezA MonteroM García-ArandaR CiérvideJ ValeroR AlonsoJ M Cárdenas-RebolloE VicenteY QuijanoA CubilloR ÁlvarezS PradosC PlazaJ GarcíaD ZuccaP Fernández-LetónC RubioPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)
The results are encouraging, suggesting that SBRT has a significant role in the management of these patients and further studies will be necessary to prove these findings.